KDM2B and pancreatic neoplasm: A study on pancreatic cancer showed that KDM2B bound to TSS, decreased the levels of H3K27me3, and regulated the expression of a series of genes, and ChIP-sequencing results showed that SAV1 is one of the potential target genes of KDM2B [11].